Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Asthma and COPD Drug Market 2016: Industry Growth, Trends and Volume Growth to 2021

Monday, October 10, 2016 4:27
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Asthma and COPD (Chronic Obstructive Pulmonary Disease) are chronic diseases characterized by airway obstruction in the lungs causing respiratory infection and fatigue. COPD is characterized by yellow phlegm in the cough and episodes of cough and wheezing at night are the characteristics of asthma. Asthma and COPD drugs are the drugs that are used to treat symptoms of Asthma and COPD. These medications are generally prescribed by the pharmacists, practitioners, asthma educators, respiratory physicians, practice nurses and allergists. Traditional therapies include anti-inflammatory glucocorticosteroid and inhaled bronchodilator. Use of these therapies results in adverse effects and sometimes may worsen the symptoms of asthma and COPD. Drug treatment of asthma mainly aims at the symptomatic relief and disease modification. Drug treatment also prevents lung damage and reduces inflammation.

The growth of the Asthma and COPD drugs market is driven by the factors such as raised level of pollution and increasing aging population. Advanced therapies of medical cure and rising disposable income are also contributing to the growth of the market. However, high cost of some of the drugs and loss of patents of major Asthma and COPD drugs are the major factors that are hampering the growth of the market. Rising entry of beta-agonists, combinational therapies and inhaled corticosteroids are few of the challenges that Asthma and COPD drugs Market is facing.

Request a Brochure of This Report, here:

Increased awareness about the timely diagnosis, early stage treatment of Asthma and COPD are creating opportunities for the growth of the market. Many companies are adopting CMO (contract manufacturing outsourcing) and focusing on new product development. This shows huge opportunity for the enlargement and expansion of the market.

Asthma and COPD Drug Disease Market Analysis

Asthma and COPD Drug disease market is segmented into asthma drugs and COPD drugs. COPD drugs segment is the largest revenue generating segment due to rise in the aging population and relative rise in the rate of COPD cases compared to asthma.

Asthma and COPD Drug Product Market Analysis

Asthma and COPD Drug product market is segmented into combination therapies, anti- inflammatories, and bronchodilators. Anti- inflammatories can be further segment into monoclonal antibodies, anti- leukotriene and inhaled corticosteroids. Bronchodilators can also be further segmented into anticholonergics, long acting bronchodilators and short acting bronchodilators. Bronchodilators segment is the largest revenue generating segment due to its long- acting bronchodilators drugs that can treat the symptoms of COPD quickly. Long- acting bronchodilators drugs are considered to be the best cure for COPD.

Do Inquiry Before Purchasing Report:

Asthma and COPD Drug Geography Market Analysis

Geographically, Market is segmented into North America, Europe, Asia Pacific and RoW. Asia Pacific is the largest revenue generating segment due to relatively rising smokers and increased exposure to environmental tobacco smoke & combustion of solid fuels.

Competitive Landscape

The key strategies adopted by the companies to expand in the Asthma and COPD drugs market are product expansion, mergers & acquisitions and agreements & collaborations. These strategies would provide efficient products and yield strong performing products that support the market regulations and finally, exhibit better customer satisfaction. Top market players include AstraZeneca, GlaxoSmithKline, Merck, Singulair, Symbicort, and Advair.

High level Analysis

Report presents detailed analysis of Asthma and COPD drugs market using Porter’s five forces model. Degree of bargaining power of consumers is expected to be high due to competition among industry leaders for innovative products. Degree of bargaining power of suppliers is expected to be moderate, due to good number of vendors present in market. Threat of new entrants is high, as the business needs moderately high capital investment.

Key Benefits

• Analysis of the Asthma and COPD drugs market on the foundation of range of segments is expounded in the report, and segmental analysis is done to categorize the leading revenue generating segment
• To study the various factors that are enhancing and restraining the development of the market that would help the stakeholders in understanding the market in detail
• Study of SWOT and analysis of the captivating strategies adopted by the players in the market is conducted and that would help in assisting the stakeholders to take actionable decision
• Analysis of the current market scenario, forecasts of the future transition trends and projected revenue of the market through 2013-2020 are expounded in the report; thus, help stakeholders analyze the market
• To find out the recent trends of the Asthma and COPD drugs market and opportunity that would unlock doors for the investors to contribute in the market, which in turn would facilitate in the extension of the strategies

Key Market Segment

Asthma and COPD drugs market is segmented on the basis of disease, product, and geography.

Market by Disease

Asthma Drugs
COPD Drugs

Market by Product

• Combination Therapies
• Anti- Inflammatories
• Monoclonal Antibodies
• Anti- Leukotriene
• Inhaled Corticosteroids
• Bronchodilators
• Anticholonergics
• Long Acting Bronchodilators
• Short Acting Bronchodolators

Market by Geography

• North America
• Europe
• Asia Pacific
• RoW

About Custom Market Insights:

Custom Market Insights is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive.

What makes us different from our competitors?

Compared to our competitors, our offerings include, but are not limited to market research services on latest industry trends, customized study at reasonable price, and database bigger than our competitors and provide more relevant results to fit your needs.

Contact Us:

Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.